Boston Scientific (BSX) Competitors

$53.33 -0.60 (-1.12%)

Closing price 03:59 PM Eastern

Extended Trading

$53.42 +0.10 (+0.18%)

As of 07:30 PM Eastern

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

Should you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Align Technology (ALGN), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), and Cardinal Health (CAH). These companies are all part of the "medical" sector.

How does Boston Scientific compare to Align Technology?

Align Technology (NASDAQ:ALGN) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

88.4% of Align Technology shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.8% of Align Technology shares are held by insiders. Comparatively, 0.3% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Boston Scientific has higher revenue and earnings than Align Technology. Boston Scientific is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.10B	2.88	$410.35M	$5.96	27.62
Boston Scientific	$20.61B	3.84	$2.90B	$2.39	22.31

Align Technology currently has a consensus price target of $205.85, suggesting a potential upside of 25.05%. Boston Scientific has a consensus price target of $93.91, suggesting a potential upside of 76.10%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.57
Boston Scientific	0 Sell rating(s)	3 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.92

Boston Scientific has a net margin of 17.29% compared to Align Technology's net margin of 10.50%. Boston Scientific's return on equity of 19.17% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	10.50%	15.82%	10.17%
Boston Scientific	17.29%	19.17%	10.77%

In the previous week, Boston Scientific had 15 more articles in the media than Align Technology. MarketBeat recorded 25 mentions for Boston Scientific and 10 mentions for Align Technology. Align Technology's average media sentiment score of 1.09 beat Boston Scientific's score of 0.66 indicating that Align Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Boston Scientific	13 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Align Technology has a beta of 1.7, suggesting that its share price is 70% more volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Summary

Boston Scientific beats Align Technology on 12 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to HealthEquity?

Boston Scientific (NYSE:BSX) and HealthEquity (NASDAQ:HQY) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

Boston Scientific has higher revenue and earnings than HealthEquity. Boston Scientific is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.61B	3.84	$2.90B	$2.39	22.31
HealthEquity	$1.31B	5.25	$215.20M	$2.46	33.19

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by company insiders. Comparatively, 1.5% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Boston Scientific has a net margin of 17.29% compared to HealthEquity's net margin of 16.39%. Boston Scientific's return on equity of 19.17% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
HealthEquity	16.39%	13.86%	8.67%

In the previous week, Boston Scientific had 15 more articles in the media than HealthEquity. MarketBeat recorded 25 mentions for Boston Scientific and 10 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.33 beat Boston Scientific's score of 0.66 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	13 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
HealthEquity	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market.

Boston Scientific presently has a consensus price target of $93.91, suggesting a potential upside of 76.10%. HealthEquity has a consensus price target of $111.79, suggesting a potential upside of 36.91%. Given Boston Scientific's stronger consensus rating and higher possible upside, equities analysts plainly believe Boston Scientific is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	0 Sell rating(s)	3 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.92
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87

Summary

Boston Scientific beats HealthEquity on 10 of the 16 factors compared between the two stocks.

How does Boston Scientific compare to Merit Medical Systems?

Boston Scientific (NYSE:BSX) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.

Boston Scientific presently has a consensus price target of $93.91, indicating a potential upside of 76.10%. Merit Medical Systems has a consensus price target of $92.80, indicating a potential upside of 53.87%. Given Boston Scientific's stronger consensus rating and higher possible upside, research analysts clearly believe Boston Scientific is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	0 Sell rating(s)	3 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.92
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

Boston Scientific has a net margin of 17.29% compared to Merit Medical Systems' net margin of 9.03%. Boston Scientific's return on equity of 19.17% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
Merit Medical Systems	9.03%	13.54%	7.94%

In the previous week, Boston Scientific had 15 more articles in the media than Merit Medical Systems. MarketBeat recorded 25 mentions for Boston Scientific and 10 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.69 beat Boston Scientific's score of 0.66 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	13 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Merit Medical Systems	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Boston Scientific has higher revenue and earnings than Merit Medical Systems. Boston Scientific is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.61B	3.84	$2.90B	$2.39	22.31
Merit Medical Systems	$1.54B	2.33	$128.49M	$2.31	26.11

Boston Scientific has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market.

Summary

Boston Scientific beats Merit Medical Systems on 13 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to AMN Healthcare Services?

Boston Scientific (NYSE:BSX) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

Boston Scientific has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.61B	3.84	$2.90B	$2.39	22.31
AMN Healthcare Services	$2.73B	0.43	-$95.70M	-$0.87	N/A

Boston Scientific has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market.

Boston Scientific presently has a consensus price target of $93.91, indicating a potential upside of 76.10%. AMN Healthcare Services has a consensus price target of $23.50, indicating a potential downside of 22.78%. Given Boston Scientific's stronger consensus rating and higher probable upside, equities analysts clearly believe Boston Scientific is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	0 Sell rating(s)	3 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.92
AMN Healthcare Services	2 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.44

In the previous week, Boston Scientific had 10 more articles in the media than AMN Healthcare Services. MarketBeat recorded 25 mentions for Boston Scientific and 15 mentions for AMN Healthcare Services. Boston Scientific's average media sentiment score of 0.66 beat AMN Healthcare Services' score of 0.65 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	13 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
AMN Healthcare Services	4 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific has a net margin of 17.29% compared to AMN Healthcare Services' net margin of -0.95%. Boston Scientific's return on equity of 19.17% beat AMN Healthcare Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
AMN Healthcare Services	-0.95%	18.01%	5.19%

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Boston Scientific beats AMN Healthcare Services on 14 of the 16 factors compared between the two stocks.

How does Boston Scientific compare to Cardinal Health?

Boston Scientific (NYSE:BSX) and Cardinal Health (NYSE:CAH) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

Boston Scientific has a net margin of 17.29% compared to Cardinal Health's net margin of 0.62%. Boston Scientific's return on equity of 19.17% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
Cardinal Health	0.62%	-92.61%	4.46%

Boston Scientific has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market.

Boston Scientific presently has a consensus target price of $93.91, suggesting a potential upside of 76.10%. Cardinal Health has a consensus target price of $241.80, suggesting a potential upside of 32.40%. Given Boston Scientific's higher probable upside, equities analysts plainly believe Boston Scientific is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	0 Sell rating(s)	3 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.92
Cardinal Health	0 Sell rating(s)	2 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.94

Boston Scientific has higher earnings, but lower revenue than Cardinal Health. Boston Scientific is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.61B	3.84	$2.90B	$2.39	22.31
Cardinal Health	$222.58B	0.19	$1.56B	$6.54	27.93

In the previous week, Boston Scientific had 7 more articles in the media than Cardinal Health. MarketBeat recorded 25 mentions for Boston Scientific and 18 mentions for Cardinal Health. Cardinal Health's average media sentiment score of 0.92 beat Boston Scientific's score of 0.66 indicating that Cardinal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	13 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Cardinal Health	12 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 87.2% of Cardinal Health shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by company insiders. Comparatively, 0.1% of Cardinal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Boston Scientific beats Cardinal Health on 11 of the 16 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BSX vs. The Competition

Export

Metric	Boston Scientific	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$79.25B	$7.85B	$6.18B	$22.92B
Dividend Yield	N/A	2.50%	2.78%	4.02%
P/E Ratio	22.31	16.79	20.66	28.92
Price / Sales	3.84	7.91	529.27	24.52
Price / Cash	13.36	17.15	27.81	19.21
Price / Book	3.23	3.51	9.77	4.65
Net Income	$2.90B	$223.05M	$3.54B	$1.07B
7 Day Performance	N/A	N/A	N/A	-1.20%
1 Month Performance	-13.59%	38.62%	6.28%	3.95%
1 Year Performance	-48.16%	4.02%	41.80%	28.96%

Boston Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BSX Boston Scientific	4.568 of 5 stars	$53.33 -1.1%	$93.91 +76.1%	-47.6%	$79.25B	$20.61B	22.31	59,000	Analyst Revision
ALGN Align Technology	4.2429 of 5 stars	$171.88 -3.9%	$205.85 +19.8%	-7.2%	$12.31B	$4.03B	28.84	20,290	Positive News
HQY HealthEquity	4.4513 of 5 stars	$82.18 -0.3%	$111.79 +36.0%	-6.2%	$6.94B	$1.31B	33.41	2,814	Positive News Analyst Downgrade
MMSI Merit Medical Systems	4.4131 of 5 stars	$62.01 flat	$92.80 +49.7%	-36.1%	$3.70B	$1.52B	26.84	7,500	Analyst Downgrade Insider Trade High Trading Volume
AMN AMN Healthcare Services	1.4524 of 5 stars	$20.76 -1.7%	$22.64 +9.0%	+31.2%	$802.34M	$2.73B	N/A	2,664	Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BSX) was last updated on 5/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

How does Boston Scientific compare to Align Technology?

Summary

How does Boston Scientific compare to HealthEquity?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Summary

How does Boston Scientific compare to Cardinal Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

How does Boston Scientific compare to Align Technology?

Do institutionals & insiders have more ownership in ALGN or BSX?

Which has preferable earnings & valuation, ALGN or BSX?

Do analysts prefer ALGN or BSX?

Is ALGN or BSX more profitable?

Does the media favor ALGN or BSX?

Which has more volatility & risk, ALGN or BSX?

Summary

How does Boston Scientific compare to HealthEquity?

Which has better valuation and earnings, BSX or HQY?

Do institutionals and insiders hold more shares of BSX or HQY?

Is BSX or HQY more profitable?

Does the media refer more to BSX or HQY?

Which has more risk & volatility, BSX or HQY?

Do analysts recommend BSX or HQY?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Do analysts recommend BSX or MMSI?

Is BSX or MMSI more profitable?

Does the media favor BSX or MMSI?

Do insiders and institutionals believe in BSX or MMSI?

Which has stronger earnings & valuation, BSX or MMSI?

Which has more risk and volatility, BSX or MMSI?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Which has higher earnings and valuation, BSX or AMN?

Which has more volatility & risk, BSX or AMN?

Do analysts recommend BSX or AMN?

Does the media refer more to BSX or AMN?

Is BSX or AMN more profitable?

Do institutionals and insiders believe in BSX or AMN?

Summary

How does Boston Scientific compare to Cardinal Health?

Is BSX or CAH more profitable?

Which has more risk & volatility, BSX or CAH?

Do analysts prefer BSX or CAH?

Which has better earnings & valuation, BSX or CAH?

Does the media refer more to BSX or CAH?

Do institutionals and insiders have more ownership in BSX or CAH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools